| abstract |
Disclosed are substituted pyridine compounds and pharmaceutical compositions and methods of use. One embodiment has the structural formula: Wherein the ring system represented by E, J, T, “B”, T, R 3 , R 4 , w and x are as described herein. In certain embodiments, the compounds disclosed herein can be used to activate the AMPK pathway and treat metabolic-related diseases and conditions. |